AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

Recursion Pharmaceuticals is positioning itself as a leader in AI-driven drug discovery, leveraging its proprietary platform to accelerate the development of therapies across multiple therapeutic ...

On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...

On February 5, 2026, OpenAI introduced GPT-5.3-Codex and wrote in its release notes that early versions of the model were “instrumental in creating itself,” helping to debug training runs, manage ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

The artificial intelligence giant said a “brake pedal” was needed to protect humanity from self-improving models. The proposal could have big consequences. By Andrew Ross Sorkin Bernhard Warner Sarah ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

05/08 Recursion Pharmaceuticals presenta sus resultados del segundo trimestre y del primer semestre de 2026 CI 05/08 Resultados trimestrales: Recursion Pharmaceuticals registra una pérdida de 0,25 USD ...

20.03. Recursion Pharmaceuticals, Inc. Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum, Mar-17-2026 03:45 PM 18.03. Recursion Pharmaceuticals, Inc. Presents at Leerink Global ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...